Monitoring the interactions between cancer cell metabolism and radiation response
Monitoring the interactions between cancer cell metabolism and radiation response
批准号:
10001058
负责人:
Aparna Kesarwala
金额:
$24.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2022-08-31
关键词:
AntioxidantsBiophysicsBrain NeoplasmsCancer PatientCellular biologyCharacteristicsCitric Acid CycleClinicalClinical TrialsCombination Drug TherapyCommittee MembersDevelopment PlansDoseEnvironmentEnzymesEquilibriumFoundationsFunctional Magnetic Resonance ImagingFutureGluconeogenesisGoalsHeadHeterogeneityHypoxiaImageIndividualInvestigationIsocitrate DehydrogenaseKnowledgeLearningMagnetic Resonance ImagingMediatingMentorsMetabolicMetabolic PathwayMetabolismMolecularMolecular TargetMonitorMutationNADPNational Cancer InstituteNormal CellPathway interactionsPentosephosphate PathwayPhasePyruvatePyruvate Metabolism PathwayRadiationRadiation OncologistRadiation OncologyRadiation ToleranceRadiation therapyRadiobiologyRadiosensitizationResearchResearch PersonnelSolid NeoplasmSpectrum AnalysisStructureTestingTherapeuticTherapy Clinical TrialsTimeTrainingTraining ProgramsTumor BiologyWarburg EffectWorkaerobic glycolysisalpha ketoglutaratebasecancer cellcareercareer developmentclinical practiceclinically relevantdesignimprovedin vivoindividual patientinnovationinterestmetabolic imagingmolecular imagingmutantnovelpersonalized medicineprogramsradiation effectradiation responsereal-time imagessmall moleculespectroscopic imagingtargeted therapy trialstumortumor metabolism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Over half of cancer patients receive radiation therapy during their course of treatment, but the current clinical
practice of radiation oncology does not adjust volumes or doses based on molecular characteristics of an
individual patient’s tumor. The existing knowledge gap between tumor biology and clinical practice limits the
ability to personalize radiation therapy. Dr. Kesarwala’s long-term scientific goal is to improve the efficacy of
radiation therapy by personalizing concurrent therapies and radiation volumes and doses based on metabolic
characteristics of tumors. She proposes to approach this goal via investigation and characterization of the
interacting effects of radiation therapy, IDH1 mutations, and hypoxia on the metabolic pathways of cancer
cells. This proposal is designed to test the hypothesis that altering cancer cell metabolism can increase
radiation response. The goals of this proposal are to characterize the effects of 1) radiation therapy, 2) IDH1
mutations, and 3) hypoxia on metabolic balance, and 4) develop small molecules for metabolic imaging. The
results from this research will significantly improve understanding of a potential target pathway for combination
drug and radiation therapy and lay the foundation for future radiation therapy clinical trials. During the
mentored phase of this proposal, she will expand upon her background in molecular imaging and cell biology
and her clinical training in radiation oncology with additional study of cancer cell metabolism and metabolic
imaging. She will be mentored by Dr. Kevin Camphausen, Senior Investigator and Chief of the Radiation
Oncology Branch at the National Cancer Institute (NCI), a translational radiation oncologist who is an expert in
brain tumors and clinical trials. Her co-mentor for this proposal is Dr. Murali Krishna Cherukuri, Senior
Investigator and Head of the Biophysical Spectroscopy Section of the Radiation Biology Branch at the NCI, a
leader and innovator in functional magnetic resonance imaging and spectroscopy. Her training program
represents a thoughtful approach to the transition to independence, combining guidance from an outstanding
team of mentors and mentoring committee members with formal coursework, a strong career development
plan, and the exceptional training environment of the NCI. The work outlined in this proposal will be the next
step towards Dr. Kesarwala’s long-term career goal, which is to become an independent investigator working
at the interface of radiation oncology, cancer metabolism, and molecular imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung Cancer
-
批准号:10575081
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2023
-
负责人:Aparna Kesarwala
-
依托单位:
Modulation of Radiation Response
-
批准号:9153989
-
项目类别:
-
资助金额:$35.33万
-
财政年份:--
-
负责人:Aparna Kesarwala
-
依托单位:
Novel Imaging Approaches to Solid Tumors
-
批准号:9556638
-
项目类别:
-
资助金额:$57.57万
-
财政年份:--
-
负责人:Aparna Kesarwala
-
依托单位:
Modulation of Radiation Response and Metabolism
-
批准号:9556637
-
项目类别:
-
资助金额:$38.38万
-
财政年份:--
-
负责人:Aparna Kesarwala
-
依托单位:
Modulation of Radiation Response and Metabolism
-
批准号:9343992
-
项目类别:
-
资助金额:$45.52万
-
财政年份:--
-
负责人:Aparna Kesarwala
-
依托单位:
Modulation of Radiation Response
-
批准号:8938201
-
项目类别:
-
资助金额:$69.26万
-
财政年份:--
-
负责人:Aparna Kesarwala
-
依托单位:
Novel Imaging Approaches to Solid Tumors
-
批准号:9343993
-
项目类别:
-
资助金额:$68.28万
-
财政年份:--
-
负责人:Aparna Kesarwala
-
依托单位:
海外基金